Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis.
about
Canadian clinical practice guidelines for acute and chronic rhinosinusitis.Alternative strategies for proof-of-principle studies of antibacterial agentsEradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitisIDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.Antimicrobial drug resistance, regulation, and research.Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation.Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.Antimicrobial resistance in Haemophilus influenzaeDosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.Population Pharmacokinetics and Penetration into Prostatic, Seminal, and Vaginal Fluid for Ciprofloxacin, Levofloxacin, and Their Combination
P2860
Q21245393-35B2A399-7899-4B0F-907E-C5AD89B7B159Q26850895-00F862A9-FA5B-4E45-B8DE-A4514FA27228Q33241517-290CE511-CE6B-44AE-AC35-5F4302C55ED6Q34262840-69959A0C-2496-4719-9836-5C9EE9FD1CFAQ36026412-E76AE26E-BC4F-4535-B9F0-F535030A102EQ36295483-D3E01910-56A7-4EAA-898C-7469C752F359Q36320613-38AB813E-38AB-470B-88C2-FDB95094B253Q36788831-F354C850-F6BD-4C90-BB39-8F1EED1CEDD4Q37988861-6244F0DE-145C-4AC7-8EA2-233190DAF52EQ43152276-9C254CD1-AA98-4CCD-A507-FDD9EAEC8F91Q57240424-AE052E0D-424B-4AE0-9FE3-0A83E6DE0B3A
P2860
Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@en
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@nl
type
label
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@en
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@nl
prefLabel
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@en
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@nl
P2093
P2860
P356
P1476
Use of pharmacodynamic end poi ...... of acute maxillary sinusitis.
@en
P2093
Jack B Anon
Joel S Owen
Marion Piedmonte
Mary Eileen McPhee
Paul G Ambrose
Ronald N Jones
Scott Van Wart
Sujata M Bhavnani
P2860
P304
P356
10.1086/420739
P407
P577
2004-05-12T00:00:00Z